Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longzhu ointment for moderate acne vulgaris
ChiCTR2400085476Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Longzhu Ointment in acne vulgaris (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoints: Percent change from baseline in inflammatory lesion count at Day 8, Percent change from baseline in inflammatory lesion count at Day 15 and 2 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Longzhu Ointment
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2400085476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085476.